Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,276 public trials 443 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults

NCT01667731

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Bronchial Diseases, +30 more
Locations
  • Birmingham, Alabama, United States
  • Coronado, California, United States
  • Los Angeles, California, United States
  • Lutherville, California, United States
View all 27 locations
View Trial Details
Completed

A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-6 Patients

NCT01263860

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • The Eighth People's Hospital of Guangzhou Guangzhou, Guangdong, China
  • The Third Affliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
  • Panyu People's Hospital Guangzhou, Guangdong, China
  • Zhongshan second people's hospital Zhongshan, Guangdong, China
View Trial Details
Completed

Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in HIV-Infected Subjects 6 Years of Age or Older Who Are Naive to Pneumococcal Vaccine

NCT00962780

Conditions
Acquired Immunodeficiency Syndrome, Bacterial Infections, Bacterial Infections and Mycoses, +18 more
Locations
  • Pfizer Investigational Site Bucharest, Romania
  • Pfizer Investigational Site Bucharest, Romania
  • Pfizer Investigational Site Constanța, Romania
  • Pfizer Investigational Site Johannesburg, Gauteng, South Africa
View Trial Details
Completed

Switching Nevirapine Immediate Release( IR) Based Regimen to Nevirapine Extended Release (XR) Based Regimen in Human Immunodeficiency Virus One (HIV-1) Infected Patients

NCT00819052

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • 1100.1526.1012 Boehringer Ingelheim Investigational Site Beverly Hills, California, United States
  • 1100.1526.1014 Boehringer Ingelheim Investigational Site Beverly Hills, California, United States
  • 1100.1526.1011 Boehringer Ingelheim Investigational Site Long Beach, California, United States
  • 1100.1526.1013 Boehringer Ingelheim Investigational Site Los Angeles, California, United States
View all 39 locations
View Trial Details

Related conditions